IIFL Securities's Stock Idea: Buy Max Healthcare Ins with Target Rs 880

On May 16, IIFL Securities issued a buy recommendation for Max Healthcare Insurance with a target price of Rs 880, indicating a potential upside of 3.6%. The current market price of Max Healthcare Insurance is Rs 849.95. The company is a leading private healthcare provider in India with a strong presence in the Delhi-NCR region and a growing presence in other parts of the country. The company has been delivering consistent financial performance, driven by increasing patient footfall, expansion of its network, and new service offerings. The positive outlook is supported by the company's strong brand, experienced management team, and favorable industry growth prospects.

About Max Healthcare Ins:

Max Healthcare Institute Limited (Max Healthcare) is a leading provider of healthcare services in India. It operates a network of over 17 hospitals and 19 primary care clinics across the country. The company offers a comprehensive range of healthcare services, including: * Emergency care * Critical care * Trauma care * Oncology * Cardiology * Neurology * Nephrology * Urology * Gastrointestinal surgery * Pediatrics * Obstetrics and gynecology Max Healthcare is committed to providing high-quality healthcare services to its patients. The company has a team of experienced and qualified healthcare professionals who are dedicated to providing compassionate and personalized care. Max Healthcare is also committed to innovation and research, and is constantly exploring new ways to improve the quality of its services.

52 Week Price Trend:

Currently trading at Rs 849.95, Max Healthcare Ins has been oscillating within a wide range of Rs 411.9 to Rs 910 over the past year. While the stock has surged significantly from its 52-week low, it is still about 7% below its all-time high. Investors should carefully consider the company's fundamentals and technical indicators before making any investment decisions. A thorough analysis of financial performance, growth prospects, market share, and competitive landscape is recommended. Monitoring the stock's price action and volume patterns can also provide valuable insights into future performance.

Stratzy's MOST Analysis:

MAXHEALTH has achieved an AA rating from Stratzy's MOST framework, indicating medium fundamental risks. The framework evaluates a company's Management, Outlook, Safety, and Trend. MAXHEALTH's strengths lie in its management's competency and the company's promising outlook. However, it faces certain safety concerns and should monitor market trends to mitigate risks. Despite the AA rating, investors should conduct further research and consider the company's specific strengths and weaknesses before making investment decisions.

Company's Fundamentals:

Max Healthcare Ins (NSE: MAXHEALTH) trades at a Stock PE (Price-to-Earnings ratio) of 76.78, indicating that investors are paying ₹76.78 for every ₹1 of earnings. Its PB Ratio (Price-to-Book Value ratio) of 10.34 suggests that the stock is trading at 10.34 times its book value, indicating a premium valuation compared to its assets. However, with a Dividend Yield of 0.12%, the stock offers a low return on investment in the form of dividends.

Fundamental and Technical information provided in this blog were last updated on 16 May, 2024

Disclaimer: The information and recommendations presented in this section, including any attached reports, are sourced from third-party providers through diverse channels. The views and opinions expressed within these materials belong solely to their respective creators. These views and opinions do not necessarily reflect the position of Stratzy Fintech Pvt Ltd. Stratzy explicitly disclaims any guarantees, express or implied, regarding the accuracy and reliability of the provided content. We strongly advise consulting with a licensed financial advisor before making any investment decisions based on this information. Remember, seeking independent financial advice is crucial.